Valar Labs

Analyzing the tumor to predict cancer treatment response

San Francisco Bay Area, United States · Founded 2021 · $22.0M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$22.0M
Last Round
$22.0M Series AJun 2024
Rounds
1

About

Valar Labs builds AI-powered diagnostic tests to predict treatment response and prognosis in oncology. Their flagship product Vesta uses AI to analyze solid tumor histology from routine pathology slides, providing oncologists and patients with actionable insights on cancer treatment decisions. The company partners with pharmaceutical companies to deploy AI algorithms that advance R&D programs by discovering biomarkers and automating screening for molecular biomarker-based patient enrollment.

Summary

Valar Labs is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2021. It has raised $22.0M in total across 1 round, most recently a $22.0M Series A round in Jun 2024. Investors include Andreessen Horowitz, Pear VC and DCVC (Data Collab).

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AJun 2024
$22.0M

Investors

Similar Companies